The latest study from the Jill Roberts Institute, "The neuropeptide neuromedin U stimulates innate lymphoid cells and type 2 inflammation," was published on September 6 in Nature. To read more, click here.     Dr. Gregory Sonnenberg wins inaugural award from the Society for Mucosal Immunology. To read more, click here.  The Kenneth Rainin Foundation awarded Dr. Iliyan Iliev and colleagues from Mount Sinai a $250,000 Synergy Award to examine the composition of the fungal community in babies born to mothers with inflammatory bowel disease. To read more, click here. Dr. Randy Longman received the Irma T. Hirschl Career Scientist Award and the New York Crohn’s Foundation Award.    

The Jill Roberts Institute for Research in Inflammatory Bowel Disease

You are here

Correction: Type I Interferon Receptor Deficiency in Dendritic Cells Facilitates Systemic Murine Norovirus Persistence Despite Enhanced Adaptive Immunity.

TitleCorrection: Type I Interferon Receptor Deficiency in Dendritic Cells Facilitates Systemic Murine Norovirus Persistence Despite Enhanced Adaptive Immunity.
Publication TypeJournal Article
Year of Publication2017
AuthorsNice, TJ, Osborne, LC, Tomov, VT, Artis, D, E Wherry, J, Virgin, HW
JournalPLoS Pathog
Volume13
Issue2
Paginatione1006223
Date Published2017 Feb
ISSN1553-7374
Abstract

[This corrects the article DOI: 10.1371/journal.ppat.1005684.].

DOI10.1371/journal.ppat.1006223
Alternate JournalPLoS Pathog.
PubMed ID28212439
PubMed Central IDPMC5315274